Abstract
Salinipostin A (Sal A) is a potent antiplasmodial marine natural product with an undefined mechanism of action. Using a Sal A-derived activity-based probe, we identify its targets in the Plasmodium falciparum parasite. All of the identified proteins contain α/β serine hydrolase domains and several are essential for parasite growth. One of the essential targets displays a high degree of homology to human monoacylglycerol lipase (MAGL) and is able to process lipid esters including a MAGL acylglyceride substrate. This Sal A target is inhibited by the anti-obesity drug Orlistat, which disrupts lipid metabolism. Resistance selections yielded parasites that showed only minor reductions in sensitivity and that acquired mutations in a PRELI domain-containing protein linked to drug resistance in Toxoplasma gondii. This inability to evolve efficient resistance mechanisms combined with the non-essentiality of human homologs makes the serine hydrolases identified here promising antimalarial targets.
Keywords:
Plasmodium falciparum; Salinipostin A; activity-based probes; chemical proteomics; lipid metabolism; malaria; natural products; serine hydrolases.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antimalarials / chemistry
-
Antimalarials / metabolism
-
Antimalarials / pharmacology*
-
Antimalarials / therapeutic use
-
Biological Products / chemical synthesis
-
Biological Products / pharmacology
-
Biological Products / therapeutic use
-
Bridged Bicyclo Compounds, Heterocyclic / chemistry*
-
Bridged Bicyclo Compounds, Heterocyclic / metabolism
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology
-
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
-
Click Chemistry
-
Drug Resistance / drug effects
-
Humans
-
Hydrolases / antagonists & inhibitors
-
Hydrolases / metabolism*
-
Lipid Metabolism / drug effects*
-
Malaria, Falciparum / drug therapy
-
Malaria, Falciparum / parasitology
-
Malaria, Falciparum / pathology
-
Monoacylglycerol Lipases / antagonists & inhibitors
-
Monoacylglycerol Lipases / genetics
-
Monoacylglycerol Lipases / metabolism
-
Orlistat / chemistry
-
Orlistat / metabolism
-
Plasmodium falciparum / drug effects
-
Protozoan Proteins / antagonists & inhibitors
-
Protozoan Proteins / genetics
-
Protozoan Proteins / metabolism*
Substances
-
Antimalarials
-
Biological Products
-
Bridged Bicyclo Compounds, Heterocyclic
-
Protozoan Proteins
-
salinipostin A
-
Orlistat
-
Hydrolases
-
Monoacylglycerol Lipases